chinese glp-1 💊🧬China has approved the world's first cAMP-biased receptor agonist for type 2 diabetes, developed by Hangzhou-based Sciwind Biosciences. Approved on Jan. 30, Ennoglutide Injection (Xianyida®) is the first Class 1 innovative China's New GLP-1 Approval Signals

Kratom is a plant that comes from Southeast Asia that has opioid-like properties

If you're not on a GLP-1, there are better-targeted options for general nutritional support

A board-certified physician shares her must-have guide to using GLP-1 medications, such as Ozempic, Wegovy, Mounjaro, and Zepbound, to reverse obesity and take charge of your health, with established strategies for maximizing your results “This book is a game-changer

Try these healthy black bean recipes.

2 oz / 57g

A team of Virta Health leaders held a webinar on13th July 2023 to explain the results of a study the company just completed assessing health plan execs current views on Ozempic and other GLP-1 medicines with a view on both clinical outcomes and cost implications for this growing category of drugs that address diabetes and obesity